Inventor · disambiguated record
Gregory Martin Harrowe
Also filed as: HARROWE GREGORY M · HARROWE GREGORY MARTIN
4 granted patents·5 pending applications·19 citations·filing 2004–2018
74Inventor score
Files withNOVARTIS VACCINES & DIAGNOSTICS INC4KAVANAUGH WILLIAM M2CHIRON CORP1NOVARTIS VACCINES & DIAGNOSTIC1ZIMMERMAN DEBORAH LEE1
Top patents by PatentIndex Score
9 records- 0189US9926371B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2016·Granted Mar 27, 2018·7 cites·17 claims
- 0289US9079956B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Granted Jul 14, 2015·11 cites·30 claims
- 0372US9522186B2M-CSF specific monoclonal antibody and uses therofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2015·Granted Dec 20, 2016·1 cites·22 claims
- 0469US11034759B2Humanized M-CSF specific monoclonal antibodies, kits, and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Granted Jun 15, 2021·0 cites·27 claims
- 0561US2018171009A1M-CSF Specific Monoclonal Antibody and Uses ThereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
- 0656US2009324604A1M-csf specific monoclonal antibody and uses thereofCHIRON CORP·Filed 2005·Application pending·0 cites
- 0752US2014093492A1Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasisZIMMERMAN DEBORAH LEE·Filed 2013·Application pending·0 cites
- 0849US2011091451A1Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasisKAVANAUGH WILLIAM M·Filed 2004·Application pending·0 cites
- 0945US2012045450A1Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasisKAVANAUGH WILLIAM M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gregory Martin Harrowe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →